136
Blazar, B. R., Jenkins, M. K., Taylor, P. A., White, J., Panoskaltsis-Mortari, A., Korngold, R.,
et al. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during
graft-versus-host disease or the primary immune response to nominal antigen. J
Immunol, v.159, n.12, Dec 15, p.5821-5833. 1997.
Bödecker, B. G. D., Newcomb, R., Yuan, P., Braufman, A. e Kelsey, W. Production of
recombinant Factor VIII from perfusion cultures: I. Large Scale Fermentation. Em:
Animal cell technology, products of today, prospects for tomorrow
. Oxford:
Butterworth-Heinemann, 1994. p.580-590
Bolt, S., Routledge, E., Lloyd, I., Chatenoud, L., Pope, H., Gorman, S. D., et al. The
generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in
vitro immunosuppressive properties. Eur J Immunol
, v.23, n.2, Feb, p.403-411. 1993.
Boyum, A. Separation of leukocytes from blood and bone marrow. . Scandinavian journal of
clinical laboratory investigation, v.21, p.97. 1968.
Brightwell, G., Poirier, V., Cole, E., Ivins, S. e Brown, K. W. Serum-dependent and cell
cycle-dependent expression from a cytomegalovirus-based mammalian expression
vector. Gene
, v.194, n.1, Jul 18, p.115-123. 1997.
Butler, M. Animal cell cultures: recent achievements and perspectives in the production of
biopharmaceuticals. Appl Microbiol Biotechnol
, v.68, n.3, Aug, p.283-291. 2005.
Caldas, C., Coelho, V., Kalil, J., Moro, A. M., Maranhao, A. Q. e Brigido, M. M.
Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework
residue in binding to antigen. Mol Immunol
, v.39, n.15, May, p.941-952. 2003.
Caldas, C., Coelho, V. P., Rigden, D. J., Neschich, G., Moro, A. M. e Brigido, M. M. Design
and synthesis of germline-based hemi-humanized single-chain Fv against the CD18
surface antigen. Protein Eng
, v.13, n.5, May, p.353-360. 2000.
Carpenter, P. A., Tso, J. Y., Press, O. W., Yu, X. e Anasetti, C. Non-FcR-binding, humanized
anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than
OKT3 and is immunosuppressive in vivo. Transplant Proc
, v.32, n.7, Nov, p.1545-
1546. 2000.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., et al.
Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl
Acad Sci U S A, v.89, n.10, May 15, p.4285-4289. 1992.
Cereghino, J. L. e Cregg, J. M. Heterologous protein expression in the methylotrophic yeast
Pichia pastoris. FEMS Microbiol Rev
, v.24, n.1, Jan, p.45-66. 2000.
Chatenoud, L. CD3-specific antibody-induced active tolerance: from bench to bedside. Nat
Rev Immunol, v.3, n.2, Feb, p.123-132. 2003.
Chatenoud, L., Baudrihaye, M. F., Chkoff, N., Kreis, H., Goldstein, G. e Bach, J. F.
Restriction of the human in vivo immune response against the mouse monoclonal
antibody OKT3. J Immunol
, v.137, n.3, Aug 1, p.830-838. 1986.